Please sign in so that we can notify you about a reply
Indications/Uses
For prevention and therapy of damages due to faulty or deficient protein metabolism in chronic renal insufficiency in connection with a limited protein food of 40 g/day (for adult) and less, i.e. generally in patents with glomerular filtration rate (GFR) below 25 mL/min.
Dosage/Direction for Use
For oral use.
Four to eight tablets, three times a day.
1 tablet/5 kg body weight/day.
Should be taken with food (swallow whole, do not chew/crush) or as prescribed by the physician.
Duration of Treatment: The product is administered as long as the glomerular filtration rate (GFR) is below 25 mL/min, and concomitantly, dietary protein is restricted to 40 g/day or less (adults).
Four to eight tablets, three times a day.
1 tablet/5 kg body weight/day.
Should be taken with food (swallow whole, do not chew/crush) or as prescribed by the physician.
Duration of Treatment: The product is administered as long as the glomerular filtration rate (GFR) is below 25 mL/min, and concomitantly, dietary protein is restricted to 40 g/day or less (adults).
Overdosage
No symptoms have been observed to date.
Administration
Should be taken with food: Swallow whole, do not chew/crush.
Contraindications
Allergy and hypersensitivity to any content of this drug; Hypercalcaemia; Disturbed amino acid metabolism; Caution use for patients with phenylketonuria.
Warnings
Ketoanalogues + Essential amino acids contains phenylalanine. It should be used with caution in phenylketonuria patients.
Special Precautions
Ketoanalogues + Essential amino acids should be taken during meals to allow proper absorption and metabolism into the corresponding amino acids. The serum calcium level should be monitored regularly. Ensure sufficient supply with lactation.
Use In Pregnancy & Lactation
No experience has been made so far with the administration of Ketoanalogues + Essential amino acids during pregnancy and lactation.
Adverse Reactions
Hypercalcemia may develop in this case, it is recommended to decrease vitamin D intake.
If the hypercalcemia persist, reduce the dosage of Ketoanalogues + Essential amino acids as well as any source of calcium.
If the hypercalcemia persist, reduce the dosage of Ketoanalogues + Essential amino acids as well as any source of calcium.
Drug Interactions
The simultaneous administration of medicaments containing calcium (e.g., acetolyte) may lead to pathological increase of the serum calcium level or intensification.
As the uraemic symptoms improve under Ketoanalogues + Essential amino adds a possible administration of aluminum hydroxide should be reduced. Pay attention to a reduction of serum phosphate. In order not to interfere with absorption, do not take drugs together with Ketoanalogues + Essential amino acids that form sparingly soluble compounds with calcium [e.g., tetracyclines, quinolone (e.g., ciprofloxacin, norfloxacin), Iron, fluoride, and estramustin-containing drugs]. Between the intake of Ketoanalogues + Essential amino acids and drugs from the mentioned categories, a period of at least 2 hours should pass. the susceptibility towards heart/cardiac-active glycosides and hence also the risk of arrhythmia increase with the rise of the blood calcium concentration.
As the uraemic symptoms improve under Ketoanalogues + Essential amino adds a possible administration of aluminum hydroxide should be reduced. Pay attention to a reduction of serum phosphate. In order not to interfere with absorption, do not take drugs together with Ketoanalogues + Essential amino acids that form sparingly soluble compounds with calcium [e.g., tetracyclines, quinolone (e.g., ciprofloxacin, norfloxacin), Iron, fluoride, and estramustin-containing drugs]. Between the intake of Ketoanalogues + Essential amino acids and drugs from the mentioned categories, a period of at least 2 hours should pass. the susceptibility towards heart/cardiac-active glycosides and hence also the risk of arrhythmia increase with the rise of the blood calcium concentration.
Storage
Store at temperatures not exceeding 30°C.
Action
Pharmacology: Pharmacodynamics: Ketoanalogues + Essential amino acids allows the intake of essential amino acids while minimizing the aminonitrogen intake. Following ingestion, the ketoanalogues are transaminated by taking nitrogen from non-essential amino acids, thereby decreasing the formation of urea by re-using the amino group.
The levels of accumulating uremic toxins are decreased. Keto- and/or hydroxy-acids do not elicit hyperfiltration of residual nephrons. Ketoacid-containing supplements have a positive influence on the renal hyperphosphatemia and secondary hyperparathyroidism and can improve renal osteodystrophy. The use of Ketoanalogues + Essential amino acids in association with a very low protein diet allows a reduced intake of nitrogen while avoiding the deleterious consequences of inadequate dietary protein intake and malnourishment.
Therapeutic action: Normalizes metabolic processes, promotes recycling product exchange, reduces ion concentration of potassium, magnesium and phosphate.
Pharmacokinetics: In normal individuals, there is an increase in the plasma level of ketoanalogues, 10 minutes after oral ingestion. These levels reach values that are approximately 5 times higher than the initial level. Peak levels are reached within 20-80 min, and normal levels are reached again after 90 min. Gastrointestinal absorption is thus very rapid. In the plasma, a simultaneous increase in levels of the ketoanalogues and the corresponding amino acid show that transamination of the ketoanalogues is very rapid. Due to the natural pathways of disposal of α-ketonic acids in the organism, it is probable that exogenous intakes are very rapidly integrated into metabolic cycles. Ketoacids follow the same catabolic pathways as the classical amino acids.
The levels of accumulating uremic toxins are decreased. Keto- and/or hydroxy-acids do not elicit hyperfiltration of residual nephrons. Ketoacid-containing supplements have a positive influence on the renal hyperphosphatemia and secondary hyperparathyroidism and can improve renal osteodystrophy. The use of Ketoanalogues + Essential amino acids in association with a very low protein diet allows a reduced intake of nitrogen while avoiding the deleterious consequences of inadequate dietary protein intake and malnourishment.
Therapeutic action: Normalizes metabolic processes, promotes recycling product exchange, reduces ion concentration of potassium, magnesium and phosphate.
Pharmacokinetics: In normal individuals, there is an increase in the plasma level of ketoanalogues, 10 minutes after oral ingestion. These levels reach values that are approximately 5 times higher than the initial level. Peak levels are reached within 20-80 min, and normal levels are reached again after 90 min. Gastrointestinal absorption is thus very rapid. In the plasma, a simultaneous increase in levels of the ketoanalogues and the corresponding amino acid show that transamination of the ketoanalogues is very rapid. Due to the natural pathways of disposal of α-ketonic acids in the organism, it is probable that exogenous intakes are very rapidly integrated into metabolic cycles. Ketoacids follow the same catabolic pathways as the classical amino acids.
MedsGo Class
Other Drugs Acting on the Genito-Urinary System
Features
Dosage
101 mg / 86 mg / 68 mg / 67 mg / 59 mg / 105 mg / 53 mg / 38 mg / 30 mg / 23 mg
Ingredients
- Amino Acid
- Ketoanalogues
Packaging
Film-Coated Tablet 1's
Generic Name
Ketoanalogues / Essential Amino Acids
Registration Number
DRP-5901-03
Classification
Prescription Drug (RX)
Reviews
No reviews found
Product Questions
Questions
